Kelly, J. P., Hunter, W., Craig, D., Haynes, C., McGarrah, R., Velazquez, E., … Shah, S. (2015). Metabolomic Profiling Identifies Biomarkers Predicting Adverse Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. In Journal of the American College of Cardiology (Vol. 65, pp. A772–A772). https://doi.org/10.1016/S0735-1097(15)60772-0

Kelly, J. P., W. Hunter, D. Craig, C. Haynes, R. McGarrah, E. Velazquez, M. Felker, et al. “Metabolomic Profiling Identifies Biomarkers Predicting Adverse Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.” In Journal of the American College of Cardiology, 65:A772–A772, 2015. https://doi.org/10.1016/S0735-1097(15)60772-0.

Kelly JP, Hunter W, Craig D, Haynes C, McGarrah R, Velazquez E, et al. Metabolomic Profiling Identifies Biomarkers Predicting Adverse Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. In: Journal of the American College of Cardiology. 2015. p. A772–A772.

Kelly, J. P., et al. “Metabolomic Profiling Identifies Biomarkers Predicting Adverse Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.” Journal of the American College of Cardiology, vol. 65, no. 10, 2015, pp. A772–A772. Manual, doi:10.1016/S0735-1097(15)60772-0.

Kelly JP, Hunter W, Craig D, Haynes C, McGarrah R, Velazquez E, Felker M, Hernandez A, Ilkayeva O, Stevens RD, Bain J, Muehlbauer M, Newgard C, Kraus W, Shah S. Metabolomic Profiling Identifies Biomarkers Predicting Adverse Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology. 2015. p. A772–A772.